Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.32 is 24% below its 5-year average of 4.38, near the low end of its 5-year range (2.01–10.63).
As of the fiscal period ended Tuesday, June 30, 2026. 17.73% above its 12-month average of 2.82.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.32.
QUICK RATIO (ACID-TEST)
3.32
QUICK RATIO (ACID-TEST) AVG TTM
2.82
QUICK RATIO (ACID-TEST) AVG 3Y
3.51
QUICK RATIO (ACID-TEST) AVG 5Y
4.38
QUICK RATIO (ACID-TEST) AVG 10Y
3.95
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+17.73%
CURRENT VS 3Y AVG
-5.42%
CURRENT VS 5Y AVG
-24.23%
CURRENT VS 10Y AVG
-15.86%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 849 covered companies
CURRENT VS SECTOR MEDIAN
-0.88%
vs the sector median at left
Sutro Biopharma, Inc.
Market Cap
$141.00M
Quick Ratio (Acid-Test)
3.32
TTM Avg
2.82
3Y Avg
3.51
5Y Avg
4.38
Market Cap
$140.49M
Quick Ratio (Acid-Test)
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
Market Cap
$143.10M
Quick Ratio (Acid-Test)
10.97
TTM Avg
15.14
3Y Avg
14.07
5Y Avg
22.68
Market Cap
$143.67M
Quick Ratio (Acid-Test)
3.83
TTM Avg
1.68
3Y Avg
1.58
5Y Avg
2.46
Market Cap
$138.93M
Quick Ratio (Acid-Test)
8.04
TTM Avg
11.45
3Y Avg
6.05
5Y Avg
5.52
Market Cap
$136.88M
Quick Ratio (Acid-Test)
2.09
TTM Avg
2.13
3Y Avg
2.85
5Y Avg
4.38
Market Cap
$145.90M
Quick Ratio (Acid-Test)
2.47
TTM Avg
5.26
3Y Avg
13.15
5Y Avg
16.36
Market Cap
$136.41M
Quick Ratio (Acid-Test)
8.73
TTM Avg
6.53
3Y Avg
6.53
5Y Avg
6.53
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sutro Biopharma, Inc. (STRO) | $141.00M | 3.32 | 2.82 | 3.51 | 4.38 |
| Immuneering Corporation (IMRX)vs › | $140.49M | 19.47 | 11.39 | 11.91 | 15.23 |
| Protara Therapeutics, Inc. (TARA)vs › | $143.10M | 10.97 | 15.14 | 14.07 | 22.68 |
| Nyxoah S.A. (NYXH)vs › | $143.10M | 2.31 | 2.75 | 4.17 | 7.24 |
| Fortress Biotech, Inc. (FBIOP)vs › | $143.67M | 3.83 | 1.68 | 1.58 | 2.46 |
| Alpha Cognition Inc (ACOG)vs › | $138.93M | 8.04 | 11.45 | 6.05 | 5.52 |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.88M | 2.09 | 2.13 | 2.85 | 4.38 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $145.90M | 2.47 | 5.26 | 13.15 | 16.36 |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.41M | 8.73 | 6.53 | 6.53 | 6.53 |
| Freenome, Inc. (FRNM)vs › | $135.08M | N/A | N/A | N/A | N/A |
Quick Ratio
3.32
Excludes inventory
Current Ratio
3.32
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.32 |
| 2026-03-31 | 3.12 |
| 2025-12-31 | 2.01 |
| 2025-09-30 | 2.53 |
| 2025-06-30 | 3.12 |
| 2025-03-31 | 2.16 |
| 2024-12-31 | 2.60 |
| 2024-09-30 | 3.09 |
| 2024-06-30 | 3.41 |
| 2024-03-31 | 4.46 |
| 2023-12-31 | 4.50 |
| 2023-09-30 | 5.18 |
| 2023-06-30 | 6.14 |
| 2023-03-31 | 5.11 |
| 2022-12-31 | 5.31 |
| 2022-09-30 | 5.95 |
| 2022-06-30 | 7.44 |
| 2022-03-31 | 5.90 |
| 2021-12-31 | 5.24 |
| 2021-09-30 | 7.07 |
| 2021-06-30 | 10.63 |
| 2021-03-31 | 11.74 |
| 2020-12-31 | 12.78 |
| 2020-09-30 | 9.77 |
| 2020-06-30 | 7.29 |
| 2020-03-31 | 3.98 |
| 2019-12-31 | 3.90 |
| 2019-09-30 | 3.78 |
| 2019-06-30 | 4.49 |
| 2019-03-31 | 5.67 |
| 2018-12-31 | 5.76 |
| 2018-09-30 | 3.45 |
| 2018-06-30 | 1.57 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.80 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
